세계의 듀얼 오렉신 수용체 길항제 시장 인사이트, 예측(-2031년)

The global Dual Orexin Receptor Antagonist market is projected to grow from US$ 670.85 million in 2024 to US$ 1,234.97 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.14% during the forecast period.

The United States & Canada market for Dual Orexin Receptor Antagonist is estimated to increase from $ 145.76 million in 2024 to reach $162.32 million by 2031, at a CAGR of 0.61% during the forecast period of 2025 through 2031.

The Japan market for Dual Orexin Receptor Antagonist is estimated to increase from $ 431.87 million in 2024 to reach $707.11 million by 2031, at a CAGR of 5.18% during the forecast period of 2025 through 2031.

The Europe market for Dual Orexin Receptor Antagonist is estimated to increase from $ 79.35 million in 2024 to reach $343.07 million by 2031, at a CAGR of 18.23% during the forecast period of 2025 through 2031.

The global key manufacturers of Dual Orexin Receptor Antagonist include Merck, Eisal, Idorsia, etc. In 2024, the global top two players had a share approximately 83.43% in terms of revenue.

Report Includes

This report presents an overview of global market for Dual Orexin Receptor Antagonist, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Dual Orexin Receptor Antagonist, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Dual Orexin Receptor Antagonist, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dual Orexin Receptor Antagonist sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2024. Identification of the major stakeholders in the global Dual Orexin Receptor Antagonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Dual Orexin Receptor Antagonist sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Merck, Eisal, Idorsia, etc.

Market Segmentation

By Company

• Merck
• Eisal
• Idorsia

Segment by Type

• Suvorexant
• Lemborexant
• Daridorexant

Segment by Application

• Hospital and Clinic
• Retail Pharmacies
• Other

Segment by Region

US & Canada

• U.S.
• Canada

Europe

Japan

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Dual Orexin Receptor Antagonist in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Dual Orexin Receptor Antagonist manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 7: Europe by Type, and by Application, sales, and revenue for each segment.

Chapter 8: Japan by Type, and by Application, sales, and revenue for each segment.

Chapter 9: ROW by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dual Orexin Receptor Antagonist sales, revenue, price, gross margin, and recent development, etc.

Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 13: The main points and conclusions of the report.

Table of Contents

1 STUDY COVERAGE

• 1.1 Dual Orexin Receptor Antagonist Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
  • 1.2.2 Suvorexant
  • 1.2.3 Lemborexant
  • 1.2.4 Daridorexant
• 1.3 Market by Application
  • 1.3.1 Global Dual Orexin Receptor Antagonist Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
  • 1.3.2 Hospital and Clinic
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 EXECUTIVE SUMMARY

• 2.1 Global Dual Orexin Receptor Antagonist Revenue Estimates and Forecasts 2020-2031
• 2.2 Global Revenue by Region
  • 2.2.1 Global Dual Orexin Receptor Antagonist Revenue by Region: 2020 VS 2024 VS 2031
  • 2.2.2 Global Dual Orexin Receptor Antagonist Revenue by Region (2020-2031)
  • 2.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Region (2020-2031)
• 2.3 Global Dual Orexin Receptor Antagonist Sales Estimates and Forecasts 2020-2031
• 2.4 Global Sales by Region
  • 2.4.1 Global Dual Orexin Receptor Antagonist Sales by Region: 2020 VS 2024 VS 2031
  • 2.4.2 Global Dual Orexin Receptor Antagonist Sales by Region (2020-2031)
  • 2.4.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Region (2020-2031)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 Japan
• 2.8 ROW

3 COMPETITION BY MANUFACTURERS

• 3.1 Global Sales by Manufacturers
  • 3.1.1 Global Dual Orexin Receptor Antagonist Sales by Manufacturers (2020-2025)
  • 3.1.2 Global Dual Orexin Receptor Antagonist Sales Market Share by Manufacturers (2020-2025)
  • 3.1.3 Global Top 3 Largest Manufacturers of Dual Orexin Receptor Antagonist in 2024
• 3.2 Global Revenue by Manufacturers
  • 3.2.1 Global Dual Orexin Receptor Antagonist Revenue by Manufacturers (2020-2025)
  • 3.2.2 Global Dual Orexin Receptor Antagonist Revenue Market Share by Manufacturers (2020-2025)
  • 3.2.3 Global Top 2 Companies by Dual Orexin Receptor Antagonist Revenue in 2024
• 3.3 Global Key Players of Dual Orexin Receptor Antagonist, Industry Ranking, 2023 VS 2024
• 3.4 Global Dual Orexin Receptor Antagonist Sales Price by Manufacturers (2020-2025)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
  • 3.5.2 Global Dual Orexin Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Product Offered and Application
• 3.8 Global Key Manufacturers of Dual Orexin Receptor Antagonist, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

• 4.1 Global Sales by Type
  • 4.1.1 Global Dual Orexin Receptor Antagonist Historical Sales by Type (2020-2025)
  • 4.1.2 Global Dual Orexin Receptor Antagonist Forecasted Sales by Type (2026-2031)
  • 4.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Type (2020-2031)
• 4.2 Global Revenue by Type
  • 4.2.1 Global Dual Orexin Receptor Antagonist Historical Revenue by Type (2020-2025)
  • 4.2.2 Global Dual Orexin Receptor Antagonist Forecasted Revenue by Type (2026-2031)
  • 4.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Type (2020-2031)
• 4.3 Global Price by Type
  • 4.3.1 Global Dual Orexin Receptor Antagonist Price by Type (2020-2025)
  • 4.3.2 Global Dual Orexin Receptor Antagonist Price Forecast by Type (2026-2031)

5 MARKET SIZE BY APPLICATION

• 5.1 Global Sales by Application
  • 5.1.1 Global Dual Orexin Receptor Antagonist Historical Sales by Application (2020-2025)
  • 5.1.2 Global Dual Orexin Receptor Antagonist Forecasted Sales by Application (2026-2031)
  • 5.1.3 Global Dual Orexin Receptor Antagonist Sales Market Share by Application (2020-2031)
• 5.2 Global Revenue by Application
  • 5.2.1 Global Dual Orexin Receptor Antagonist Historical Revenue by Application (2020-2025)
  • 5.2.2 Global Dual Orexin Receptor Antagonist Forecasted Revenue by Application (2026-2031)
  • 5.2.3 Global Dual Orexin Receptor Antagonist Revenue Market Share by Application (2020-2031)
• 5.3 Global Price by Application
  • 5.3.1 Global Dual Orexin Receptor Antagonist Price by Application (2020-2025)
  • 5.3.2 Global Dual Orexin Receptor Antagonist Price Forecast by Application (2026-2031)

6 US & CANADA

• 6.1 US & Canada Market Size by Type
  • 6.1.1 US & Canada Dual Orexin Receptor Antagonist Sales by Type (2020-2031)
  • 6.1.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)
• 6.2 US & Canada Market Size by Application
  • 6.2.1 US & Canada Dual Orexin Receptor Antagonist Sales by Application (2020-2031)
  • 6.2.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)
• 6.3 US & Canada Market Size by Country
  • 6.3.1 US & Canada Dual Orexin Receptor Antagonist Revenue by Country: 2020 VS 2024 VS 2031
  • 6.3.2 US & Canada Dual Orexin Receptor Antagonist Revenue by Country (2020-2031)
  • 6.3.3 US & Canada Dual Orexin Receptor Antagonist Sales by Country (2020-2031)
  • 6.3.4 US
  • 6.3.5 Canada

7 EUROPE

• 7.1 Europe Market Size by Type
  • 7.1.1 Europe Dual Orexin Receptor Antagonist Sales by Type (2020-2031)
  • 7.1.2 Europe Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)
• 7.2 Europe Market Size by Application
  • 7.2.1 Europe Dual Orexin Receptor Antagonist Sales by Application (2020-2031)
  • 7.2.2 Europe Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)

8 JAPAN

• 8.1 Japan Market Size by Type
  • 8.1.1 Japan Dual Orexin Receptor Antagonist Sales by Type (2020-2031)
  • 8.1.2 Japan Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)
• 8.2 Japan Market Size by Application
  • 8.2.1 Japan Dual Orexin Receptor Antagonist Sales by Application (2020-2031)
  • 8.2.2 Japan Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)

9 ROW

• 9.1 ROW Market Size by Type
  • 9.1.1 ROW Dual Orexin Receptor Antagonist Sales by Type (2020-2031)
  • 9.1.2 ROW Dual Orexin Receptor Antagonist Revenue by Type (2020-2031)
• 9.2 ROW Market Size by Application
  • 9.2.1 ROW Dual Orexin Receptor Antagonist Sales by Application (2020-2031)
  • 9.2.2 ROW Dual Orexin Receptor Antagonist Revenue by Application (2020-2031)

10 CORPORATE PROFILE

• 10.1 Merck
  • 10.1.1 Merck Company Information
  • 10.1.2 Merck Overview
  • 10.1.3 Merck Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
  • 10.1.4 Merck Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
  • 10.1.5 Merck Recent Developments
• 10.2 Eisal
  • 10.2.1 Eisal Company Information
  • 10.2.2 Eisal Overview
  • 10.2.3 Eisal Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
  • 10.2.4 Eisal Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
  • 10.2.5 Eisal Recent Developments
• 10.3 Idorsia
  • 10.3.1 Idorsia Company Information
  • 10.3.2 Idorsia Overview
  • 10.3.3 Idorsia Dual Orexin Receptor Antagonist Sales, Price, Revenue and Gross Margin (2020-2025)
  • 10.3.4 Idorsia Dual Orexin Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
  • 10.3.5 Idorsia Recent Developments

11 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

• 11.1 Dual Orexin Receptor Antagonist Industry Chain Analysis
• 11.2 Dual Orexin Receptor Antagonist Key Raw Materials
  • 11.2.1 Key Raw Materials
  • 11.2.2 Raw Materials Key Suppliers
• 11.3 Dual Orexin Receptor Antagonist Production Mode & Process
• 11.4 Dual Orexin Receptor Antagonist Sales and Marketing
  • 11.4.1 Dual Orexin Receptor Antagonist Sales Channels
  • 11.4.2 Dual Orexin Receptor Antagonist Distributors
• 11.5 Dual Orexin Receptor Antagonist Customers

12 DUAL OREXIN RECEPTOR ANTAGONIST MARKET DYNAMICS

• 12.1.1 Dual Orexin Receptor Antagonist Industry Trends
• 12.1.2 Dual Orexin Receptor Antagonist Market Drivers
• 12.1.3 Dual Orexin Receptor Antagonist Market Challenges
• 12.1.4 Dual Orexin Receptor Antagonist Market Restraints

13 KEY FINDINGS IN THE GLOBAL DUAL OREXIN RECEPTOR ANTAGONIST STUDY

14 APPENDIX

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details
• 14.3 Disclaimer 96